Literature DB >> 19865076

Effects of treatment for tobacco dependence on resting cerebral glucose metabolism.

Matthew R Costello1, Mark A Mandelkern, Stephen Shoptaw, Stephanie Shulenberger, Stephanie K Baker, Anna L Abrams, Catherine Xia, Edythe D London, Arthur L Brody.   

Abstract

While bupropion HCl and practical group counseling (PGC) are commonly used treatments for tobacco dependence, the effects of these treatments on brain function are not well established. For this study, 54 tobacco-dependent cigarette smokers underwent resting (18)F-fluorodeoxyglucose-positron emission tomography (FDG-PET) scanning before and after 8 weeks of treatment with bupropion HCl, PGC, or pill placebo. Using Statistical Parametric Mapping (SPM 2), changes in cerebral glucose metabolism from before to after treatment were compared between treatment groups and correlations were determined between amount of daily cigarette usage and cerebral glucose metabolism. Compared with placebo, the two active treatments (bupropion HCl and PGC) had reductions in glucose metabolism in the posterior cingulate gyrus. Further analysis suggested that PGC had a greater effect than bupropion HCl on glucose metabolism in this region. We also found positive correlations between daily cigarette use and glucose metabolism in the left occipital gyrus and parietal-temporal junction. There were no significant negative correlations between daily cigarette use and glucose metabolism. Our findings suggest that bupropion HCl and PGC reduce neural activity much as the performance of a goal-oriented task does in the default mode network of the brain, including the posterior cingulate gyrus. Thus, this study supports the theory that active treatments for tobacco dependence move the brain into a more goal-oriented state.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19865076      PMCID: PMC2813904          DOI: 10.1038/npp.2009.165

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  48 in total

Review 1.  Individual behavioural counselling for smoking cessation.

Authors:  T Lancaster; L F Stead
Journal:  Cochrane Database Syst Rev       Date:  2000

Review 2.  Drugs of abuse and the brain.

Authors:  A I Leshner; G F Koob
Journal:  Proc Assoc Am Physicians       Date:  1999 Mar-Apr

3.  Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings.

Authors:  A L Brody; S Saxena; P Stoessel; L A Gillies; L A Fairbanks; S Alborzian; M E Phelps; S C Huang; H M Wu; M L Ho; M K Ho; S C Au; K Maidment; L R Baxter
Journal:  Arch Gen Psychiatry       Date:  2001-07

Review 4.  Smoking cessation.

Authors:  Bernard Karnath
Journal:  Am J Med       Date:  2002-04-01       Impact factor: 4.965

5.  Effects of bupropion SR on anterior paralimbic function during waking and REM sleep in depression: preliminary findings using.

Authors:  E A Nofzinger; S Berman; A Fasiczka; J M Miewald; C C Meltzer; J C Price; R C Sembrat; A Wood; M E Thase
Journal:  Psychiatry Res       Date:  2001-04-10       Impact factor: 3.222

6.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

7.  Performance characteristics of a whole-body PET scanner.

Authors:  T R DeGrado; T G Turkington; J J Williams; C W Stearns; J M Hoffman; R E Coleman
Journal:  J Nucl Med       Date:  1994-08       Impact factor: 10.057

8.  Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment.

Authors:  K O Fagerström
Journal:  Addict Behav       Date:  1978       Impact factor: 3.913

9.  Nicotine blood levels and subjective craving for cigarettes.

Authors:  M E Jarvik; D C Madsen; R E Olmstead; P N Iwamoto-Schaap; J L Elins; N L Benowitz
Journal:  Pharmacol Biochem Behav       Date:  2000-07       Impact factor: 3.533

Review 10.  Searching for a baseline: functional imaging and the resting human brain.

Authors:  D A Gusnard; M E Raichle; M E Raichle
Journal:  Nat Rev Neurosci       Date:  2001-10       Impact factor: 34.870

View more
  10 in total

1.  Altered spontaneous brain activity in heavy smokers revealed by regional homogeneity.

Authors:  Guangyao Wu; Shiqi Yang; Ling Zhu; Fuchun Lin
Journal:  Psychopharmacology (Berl)       Date:  2015-02-27       Impact factor: 4.530

Review 2.  Neuroimaging the Effectiveness of Substance Use Disorder Treatments.

Authors:  Elizabeth A Cabrera; Corinde E Wiers; Elsa Lindgren; Gregg Miller; Nora D Volkow; Gene-Jack Wang
Journal:  J Neuroimmune Pharmacol       Date:  2016-05-16       Impact factor: 4.147

3.  Effect of bupropion treatment on brain activation induced by cigarette-related cues in smokers.

Authors:  Christopher S Culbertson; Jennifer Bramen; Mark S Cohen; Edythe D London; Richard E Olmstead; Joanna J Gan; Matthew R Costello; Stephanie Shulenberger; Mark A Mandelkern; Arthur L Brody
Journal:  Arch Gen Psychiatry       Date:  2011-01-03

4.  A preliminary study of the neural effects of behavioral therapy for substance use disorders.

Authors:  Elise E DeVito; Patrick D Worhunsky; Kathleen M Carroll; Bruce J Rounsaville; Hedy Kober; Marc N Potenza
Journal:  Drug Alcohol Depend       Date:  2011-10-29       Impact factor: 4.492

5.  A Study of the Feasibility of FDG-PET/CT to Systematically Detect and Quantify Differential Metabolic Effects of Chronic Tobacco Use in Organs of the Whole Body-A Prospective Pilot Study.

Authors:  Drew A Torigian; Judith Green-McKenzie; Xianling Liu; Frances S Shofer; Thomas Werner; Catherine E Smith; Andrew A Strasser; Mateen C Moghbel; Ami H Parekh; Grace Choi; Marcus D Goncalves; Natalie Spaccarelli; Saied Gholami; Prithvi S Kumar; Yubing Tong; Jayaram K Udupa; Clementina Mesaros; Abass Alavi
Journal:  Acad Radiol       Date:  2016-10-18       Impact factor: 3.173

Review 6.  Neuroscience of behavioral and pharmacological treatments for addictions.

Authors:  Marc N Potenza; Mehmet Sofuoglu; Kathleen M Carroll; Bruce J Rounsaville
Journal:  Neuron       Date:  2011-02-24       Impact factor: 17.173

Review 7.  Common and distinct neural targets of treatment: changing brain function in substance addiction.

Authors:  Anna B Konova; Scott J Moeller; Rita Z Goldstein
Journal:  Neurosci Biobehav Rev       Date:  2013-10-16       Impact factor: 8.989

Review 8.  Cognitive interventions for addiction medicine: Understanding the underlying neurobiological mechanisms.

Authors:  Anna Zilverstand; Muhammad A Parvaz; Scott J Moeller; Rita Z Goldstein
Journal:  Prog Brain Res       Date:  2015-11-14       Impact factor: 2.453

9.  Comparing the Effects of Bupropion and Escitalopram on Excessive Internet Game Play in Patients with Major Depressive Disorder.

Authors:  Beomwoo Nam; Sujin Bae; Sun Mi Kim; Ji Seon Hong; Doug Hyun Han
Journal:  Clin Psychopharmacol Neurosci       Date:  2017-11-30       Impact factor: 2.582

10.  Environmental Tobacco Smoke During the Early Postnatal Period of Mice Interferes With Brain 18 F-FDG Uptake From Infancy to Early Adulthood - A Longitudinal Study.

Authors:  Larissa Helena Torres; Caroline Cristiano Real; Walter Miguel Turato; Lídia Wiazowski Spelta; Ana Carolina Cardoso Dos Santos Durão; Tatiana Costa Andrioli; Lorena Pozzo; Peterson Lima Squair; Marco Pistis; Daniele de Paula Faria; Tania Marcourakis
Journal:  Front Neurosci       Date:  2020-01-29       Impact factor: 4.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.